205 related articles for article (PubMed ID: 21915270)
1. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
[TBL] [Abstract][Full Text] [Related]
2. A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.
de Whalley P; Walker W; Snape MD; Oeser C; Casey M; Moulsdale P; Harrill C; Andrews N; Hoschler K; Thompson B; Jones C; Chalk J; Kerridge S; Tomlinson R; Heath PT; Finn A; Faust S; Miller E; Pollard AJ
Health Technol Assess; 2011 Dec; 15(45):v-vi, xi-xiii, 1-128. PubMed ID: 22257497
[TBL] [Abstract][Full Text] [Related]
3. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
[TBL] [Abstract][Full Text] [Related]
4. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
[TBL] [Abstract][Full Text] [Related]
5. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study.
Dowse GK; Smith DW; Kelly H; Barr I; Laurie KL; Jones AR; Keil AD; Effler P
Med J Aust; 2011 Jan; 194(2):68-72. PubMed ID: 21241219
[TBL] [Abstract][Full Text] [Related]
6. H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.
Walker WT; de Whalley P; Andrews N; Oeser C; Casey M; Michaelis L; Hoschler K; Harrill C; Moulsdale P; Thompson B; Jones C; Chalk J; Kerridge S; John TM; Okike I; Ladhani S; Tomlinson R; Heath PT; Miller E; Faust SN; Snape MD; Finn A; Pollard AJ
Clin Infect Dis; 2012 Mar; 54(5):661-9. PubMed ID: 22267719
[TBL] [Abstract][Full Text] [Related]
7. Continued high incidence of children with severe influenza A(H1N1)pdm09 admitted to paediatric intensive care units in Germany during the first three post-pandemic influenza seasons, 2010/11-2012/13.
Streng A; Prifert C; Weissbrich B; Liese JG;
BMC Infect Dis; 2015 Dec; 15():573. PubMed ID: 26678835
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.
Vesikari T; Richardus JH; Berglund J; Korhonen T; Flodmark CE; Lindstrand A; Silfverdal SA; Bambure V; Caplanusi A; Dieussaert I; Roy-Ghanta S; Vaughn DW
Pediatr Infect Dis J; 2015 Jul; 34(7):774-82. PubMed ID: 26069949
[TBL] [Abstract][Full Text] [Related]
9. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.
Yang P; Zhang L; Shi W; Lu G; Cui S; Peng X; Zhang D; Liu Y; Liang H; Pang X; Wang Q
Influenza Other Respir Viruses; 2012 Nov; 6(6):381-8. PubMed ID: 22212858
[TBL] [Abstract][Full Text] [Related]
11. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
[TBL] [Abstract][Full Text] [Related]
12. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.
Tsai TF; Pedotti P; Hilbert A; Lindert K; Hohenboken M; Borkowski A; Groth N; da Silva LJ; Kyaw MH
Euro Surveill; 2010 Jul; 15(30):. PubMed ID: 20684814
[TBL] [Abstract][Full Text] [Related]
13. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
14. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.
Waddington CS; Walker WT; Oeser C; Reiner A; John T; Wilkins S; Casey M; Eccleston PE; Allen RJ; Okike I; Ladhani S; Sheasby E; Hoschler K; Andrews N; Waight P; Collinson AC; Heath PT; Finn A; Faust SN; Snape MD; Miller E; Pollard AJ
BMJ; 2010 May; 340():c2649. PubMed ID: 20508026
[TBL] [Abstract][Full Text] [Related]
17. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.
Cox CM; Goodin K; Fisher E; Dawood FS; Hamilton JJ; Leparc GF; Gray M; Nelson L; Borse RH; Singleton JA; Reed C; Balish AL; Katz JM; Hopkins RS; Fry AM
PLoS One; 2011; 6(12):e29301. PubMed ID: 22206008
[TBL] [Abstract][Full Text] [Related]
19. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
[TBL] [Abstract][Full Text] [Related]
20. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
Van Kerkhove MD; Hirve S; Koukounari A; Mounts AW;
Influenza Other Respir Viruses; 2013 Sep; 7(5):872-86. PubMed ID: 23331969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
